BPC-157 / TB-500 5mg / 5mg

“Wolverine Protocol”

For Research Purposes Only

Our BPC-157 / TB-500 blend combines two extensively studied synthetic peptides in a precision-formulated 5mg / 5mg dual-compound vial. Manufactured under strict quality standards, this product is third-party tested to ensure >99% purity and high batch consistency for laboratory research applications.

Product Specifications

    •    Compound 1: BPC-157 – 5mg

    •    Compound 2: TB-500 (Thymosin Beta-4 Fragment) – 5mg

    •    Total Peptide Content: 10mg per vial

    •    Purity: >99% (HPLC verified)

    •    Appearance: Lyophilized white powder

    •    Testing: Third-party analytical verification

    •    Storage: Store refrigerated at 2–8°C

Research Background

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a partial sequence of human gastric protein. In preclinical models, it has been investigated for its potential role in cellular repair processes, angiogenesis signaling pathways, and connective tissue research.

TB-500 is a synthetic version of the active region of Thymosin Beta-4, a naturally occurring peptide involved in actin regulation. It has been studied in laboratory settings for its effects on cell migration, tissue remodeling mechanisms, and regenerative signaling pathways.

The combination of these two peptides has been explored in research models evaluating synergistic mechanisms in tissue recovery and cellular repair processes — hence the nickname “Wolverine Protocol.”